RxDoctor Payments Data

John King, MD

Surgery · Tulsa, OKNPI 1467451237

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (28.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by TELA Bio, Inc. at 52.6% of the total. Reporting peaked in 2024 at $6,880 and has fallen 90.7% since, to $642 in 2025. Among surgery clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,842in general payments, 2019–2025

Across 124 payments — averaging $192.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$13K
  • Intuitive Surgical$10K
  • Kerecis Limited$382
  • Davol Inc.$308
  • Intra-sana Laboratories$285
  • Distalmotion US$263
  • plus $316 from 5 others

What the payments were for

  • Consulting fees$5,25022%
  • Travel & lodging$6,75928%
  • Food & beverage$6,33327%
  • Education$5,50023%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,842 in reported general payments places this provider in the 95th percentile of 290 surgery providers in Oklahoma.

See all surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$113,346
Medicare patients
202
Services billed
410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl191$757
Metaxalone36$641
Oxycodone Hcl121$592
Tramadol Hcl61$196
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$158
Naproxen101$156

Paid to pharmacies, not to this prescriber.

Other surgery in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →